We are live on
!
Find out more
ATI
Act Two Investors Portfolio holdings
AUM
$453M
1-Year Est. Return
10.9%
This Fund
S&P 500
This Quarter
Est. Return
-10.18%
1 Year Est. Return
+10.9%
3 Year Est. Return
+52.85%
5 Year Est. Return
+67.7%
10 Year Est. Return
–
AUM
$453M
AUM Growth
-$103M
(-18%)
Cap. Flow
-$51.1M
Cap. Flow
% of AUM
-11.28%
Top 10 Holdings %
Top 10 Hldgs %
73.98%
Holding
40
New
2
Increased
4
Reduced
20
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLM Corp
SLM
|
+$15.8M |
| 2 |
Automatic Data Processing
ADP
|
+$10.7M |
| 3 |
Intuit
INTU
|
+$5.57M |
| 4 |
Walt Disney
DIS
|
+$3.38M |
| 5 |
Visa
V
|
+$490K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$32.3M |
| 2 |
Adobe
ADBE
|
+$17M |
| 3 |
Canadian National Railway
CNI
|
+$11.7M |
| 4 |
Netflix
NFLX
|
+$5.71M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$5.53M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 27.68% |
| 2 | Technology | 23.49% |
| 3 | Financials | 12.74% |
| 4 | Healthcare | 10.93% |
| 5 | Consumer Discretionary | 8.76% |
Similar funds
FNB
VV
CFG
AA
MCM
TPWM
GSIAS
HIM
Act Two Investors's Q1 2026 Portfolio in Review
As of Q1 2026, Act Two Investors held 40 positions worth $453M, down 18% from $556M the previous quarter. Its ten largest holdings account for 74% of the portfolio.
Act Two Investors withdrew a net $51.1M in Q1 2026, closing 4 positions and reducing 20 holdings. Its most notable exit was AstraZeneca, an estimated $32.3M position sold in full.
By sector, the portfolio is most concentrated in Communication Services at 28% of assets, up from 26% a quarter earlier, followed by Technology and Financials.
Against the trend, Act Two Investors opened a new position in Automatic Data Processing worth $9.51M.
- Act Two Investors's largest Q1 2026 buy was Automatic Data Processing: 46,829 shares worth $9.51M.
- Act Two Investors added most to SLM Corp in Q1 2026, an estimated $15.8M increase.
- Act Two Investors's biggest Q1 2026 reduction was Canadian National Railway, cutting an estimated $11.7M.
- Act Two Investors fully exited AstraZeneca in Q1 2026, selling an estimated $32.3M.
- Act Two Investors's ten largest holdings make up 74% of its $453M portfolio in Q1 2026.
- Act Two Investors opened 2 new positions and closed 4 in Q1 2026.
- Act Two Investors's portfolio value fell 18% quarter-over-quarter to $453M.
Based on Act Two Investors's 13F filing for Q1 2026, filed 8 May 2026.